Developer docs
API playgroundTry for free, no card

Search company profiles

Mentice

Full company profile

uuid0006e83

Namestring
Mentice
Legal namestring
Mentice AB
Websiteurl
mentice.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Mentice AB is a Swedish medical simulation company founded in 1999 and headquartered in Gothenburg, building virtual reality and physical simulation platforms for image-guided interventional therapies (IGIT). The company's core technology is the VIST (Vascular Intervention Simulation Trainer) hardware line (VIST G5 and G7), which uses haptic feedback, procedural replication, and integration with live angiosuites and interventional robotics to train and credential interventional neuroradiologists, cardiologists, and radiologists across neurovascular, cardiovascular, and peripheral vascular procedures. The portfolio also includes Physiological Flow Systems that reproduce realistic vascular disease states, the Vascular Twin (case-it) patient-specific anatomical replicator, the LAACS and Replicator PRO devices, and procedural learning modules covering more than 25 clinical areas. Following the 2022 acquisition of Ankyras from Galgo Medical S.L., Mentice operates a regulated clinical decision support application for intracranial flow diverter sizing, with manufacturing and R&D housed in Mentice Spain S.L. in Barcelona.

The company earns revenue through one-time hardware sales of simulator platforms and consumables (silicone and 3D-printed vessels, blood solutions, clot replication materials), recurring software revenue from AnkyRAS, Mentice Live, and learning modules, and professional services covering installation, training, and extended warranty. Pricing is quote-based under multi-year enterprise contracts, sold via direct field sales to healthcare systems and MedTech OEMs and supported by regional distributors in international markets. Named partners include Siemens Healthineers, Stryker, Cordis, and the Jacobs Institute. Mentice reports 115 employees, presence in 8 countries, and turnover of SEK 279 million in 2025, with strategic focus split between practicing physicians and trainees, healthcare executives standardizing training programs, and MedTech industry partners using Mentice solutions for device development, sales demonstration, and professional education.

Short descriptiontext

Mentice builds VR and physical simulation platforms for image-guided interventional therapies, serving practicing interventional physicians, healthcare systems, and MedTech companies across neurovascular, cardiovascular, and peripheral vascular procedures. Its portfolio includes VIST simulators, Ankyras clinical decision support, and physiological flow systems.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersGothenburg, Sweden
HQ citystring
Gothenburg
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical simulation platforms, interventional radiology training, vascular intervention simulation, clinical decision support, endovascular procedure training
Industry3 codes
PRIMARYEDAFAJAC
Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction)
Education/Education Technology (EdTech) & Digital Learning/AR/VR/XR, Simulations & Immersive Learning
SECONDARYEDAFAJAJ
Digital Twins & Scenario-Based Systems Training (Equipment/Process Simulators)
Education/Education Technology (EdTech) & Digital Learning/AR/VR/XR, Simulations & Immersive Learning
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Simulation and Training
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Virtual Simulation Platforms and Hardware
TypeHardware Sales
Description

Sale of VR simulator platforms (VIST G5, VIST G7) and related hardware including flow systems, silicone vessels, and accessories. These are physical products sold as one-time purchases with associated consumables and service contracts.

mentice.com
2Software Licenses and Subscriptions
TypeSubscription Recurring
Description

Software solutions including procedural learning modules, ANKYRAS clinical decision support application, and cloud-based Mentice Live platform. May include subscription-based access to software updates and cloud services.

mentice.com
3Professional Services
TypeProfessional Services
Description

Installation, training, and extended warranty services, as well as device and procedural development services for MedTech industry partners

mentice.com
4Consumables
TypeHardware Sales
Description

Flow system accessories including realistic blood solutions, clot replication materials, and cleaning solutions for physical simulators

mentice.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Pricing details1 tier
1Enterprise healthcare systems pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Custom quotation for healthcare systems including simulation platforms, modules, and service contracts

mentice.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Ankyras
Description

Clinical decision support application for flow diverter sizing in intracranial aneurysm treatment

mentice.com
+6 more records
Core offering1 text field

Mentice develops and sells virtual reality and physical simulation platforms for image-guided interventional therapies, including endovascular, neurovascular, cardiovascular, and peripheral vascular procedures. Its core product family is the VIST (Vascular Intervention Simulation Trainer) platform (G5 and G7), complemented by the Ankyras clinical decision support application for flow diverter sizing, Mentice Live cloud-based proctoring, Vascular Twin patient-specific anatomical replication, Physiological Flow Systems, and related consumables and learning modules used by hospitals, physicians, and MedTech companies.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Mentice is a specialist in proficiency-based simulation solutions for image-guided interventional therapies (IGIT), offering both virtual reality and physical simulation platforms. The product portfolio centers on VIST (Vascular Intervention Simulation Trainer) hardware platforms (VIST G5 and G7), complemented by Ankyras (acquired 2022) for clinical decision support in flow diverter sizing, Vascular Twin for patient-specific anatomical replication, and cloud/mobile applications including Mentice Live and the Right Heart Cath App. The ecosystem includes Procedural Learning Modules (25+ clinical areas), Physiological Flow Systems for physical simulation, and supporting consumables. Solutions serve healthcare professionals (practicing physicians, residents, fellows) and MedTech industry (R&D, sales, professional education) across neurovascular, cardiovascular, and peripheral vascular specialties. Mentice operates from Gothenburg, Sweden with 115 employees and presence in 8 countries.

Product and service10 records
1VIST G7 Simulator
CategoryVirtual Reality Medical Simulator
Description

Latest generation virtual reality vascular intervention simulation platform with advanced haptic feedback for realistic catheter and device manipulation training in neurovascular, cardiovascular, and peripheral vascular procedures; used by hospitals, training programs, and MedTech companies.

2VIST G5 Simulator
CategoryVirtual Reality Medical Simulator
Description

Fifth generation haptic device-based endovascular simulator enabling realistic catheter and device manipulation training for interventional procedures; targeted at healthcare systems and training programs.

3Ankyras
CategoryClinical Decision Support Software
Description

Clinical decision support software application that imports patient anatomy and determines the optimal flow diverter size for intracranial aneurysm treatment; used by interventional neuroradiologists and neurosurgeons, with CE MDR, UKCA, FDA 510(k), and ANVISA clearances.

4Mentice Live
CategoryCloud Training Platform
Description

Cloud-based platform combining remote proctoring and online learning capabilities with medical simulation, enabling distributed training, curriculum delivery, and remote expert guidance for interventional teams.

5Vascular Twin (case-it)
CategoryPatient-Specific Simulation Software
Description

Real anatomical replication solution that imports patient CT, MRI, or 3DRA imaging to build a library of patient-specific cases for pre- and post-intervention practice.

6Right Heart Cath App
CategoryMobile Medical Training Application
Description

Mobile application providing interactive, real-time exploration of the right heart catheterization (RHC) procedure for portable training access by interventional cardiologists and trainees.

7Physiological Flow Systems
CategoryPhysical Medical Simulation Equipment
Description

Physical simulation systems that replicate valvular, peripheral, aortic vascular, and neurovascular disease states with realistic blood flow for device and procedural training and adoption; used by hospitals and medical device manufacturers.

8Silicone & 3D Printed Vessels
CategorySimulation Consumables
Description

Patient-specific anatomical vessels in silicone and 3D printed formats, ordered to patient anatomy or chosen from a catalogue of anatomies for physical simulation training.

9Flow System Accessories
CategorySimulation Consumables
Description

Consumables for physical flow simulators, including realistic SIMulant blood solutions, clot replication and extraction materials, and cleaning solutions.

10Professional Services
CategoryProfessional Services
Description

Professional services covering installation, training, and extended warranty for Mentice simulation platforms, plus device and procedural development services for MedTech industry partners.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeOthersAnnounced on2022-11-09
Description

Swedish government innovation agency providing 3 million SEK grant to enhance realism in virtual reality software and synthetic image generation for medical AI training as part of the TASTI initiative within the European Eureka Xecs cluster.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-06-09
Description

Acquired all assets related to the Ankyras software solution for approximately EUR 2.775 million in cash. Ankyras provides flow diverter sizing for intracranial aneurysm treatment planning.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Co-marketing partnership to advance neurovascular treatment planning. The partnership combines Mentice's simulation expertise with Siemens Healthineers' imaging technology to provide integrated solutions for neurovascular procedures.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Healthcare innovation partner focused on advancing medical device development and training. Mentice provides simulation technology for the institute's education and research programs.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Strategic MedTech partner using Mentice simulation solutions for device adoption, physician training, and demonstrating clinical credibility of their medical devices.

Strategic tierCoreTypeGTM or Marketing Partner
Description

MedTech industry partner leveraging Mentice solutions for procedural training and professional education related to Cordis medical devices.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Swedish-headquartered medical simulation company offering virtual reality training platforms for interventional and surgical procedures. The closest direct competitor to Mentice, with overlapping endovascular, cardiovascular, and minimally invasive surgery simulation product lines and a shared Gothenburg regional base.

TypeDirect peer
Description

Swiss developer of high-fidelity virtual reality simulators for endovascular, laparoscopic, and ultrasound-guided procedures. Directly competes with Mentice in interventional cardiology, interventional radiology, and vascular access training served to the same MedTech and hospital buyers.

TypeDirect peer
Description

3D Systems' healthcare division produces the Simbionix line of VR-based procedural simulators for endovascular, bronchoscopy, GI, and general surgery. It is a direct competitor in virtual interventional simulation with comparable procedural content and an established global installed base.

TypeBroad incumbent
Description

Healthcare division of CAE Inc. providing a broad portfolio of simulation-based training solutions spanning patient, ultrasound, interventional, and surgical modalities. While larger and broader than Mentice, it competes in healthcare simulation procurement at large hospital systems and MedTech training programs.

TypeBroad incumbent
Description

Norwegian-based global leader in medical simulation, including patient, emergency, and resuscitation training. While focused on patient simulators rather than interventional procedures, it competes at the healthcare-system training budget level and brings significant scale and distribution.

TypeBroad incumbent
Description

U.S.-based manufacturer of patient simulators and simulation-based training solutions used across nursing, medical, and emergency response education. Operates broadly across healthcare simulation procurement where Mentice also targets healthcare executive buyers.

7Osso VR
TypeEmerging player
Description

VR-based surgical and procedural training platform for orthopedic, spine, and interventional procedures. Offers a software-first, more scalable model that competes with Mentice on content breadth and remote training capability (overlapping with Mentice Live).

TypeEmerging player
Description

Haptic-enabled VR surgical training platform deployed via SaaS to MedTech and hospital customers. Competes with Mentice in MedTech professional education and surgical skills training, with a more software-centric approach.

9Medical-X
TypeDirect peer
Description

Netherlands-based developer of virtual reality and simulation-based training systems for minimally invasive surgery, endovascular, and interventional procedures. A direct competitor at the specialty-procedural simulator level with comparable product pricing tiers.

TypeEmerging player
Description

U.K.-based developer of synthetic and digital training solutions for surgical and interventional procedures, including laparoscopic and endovascular simulators. An emerging competitor addressing a portion of Mentice's procedural training market with cost-positioned offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mentice

Medical Simulation and Trainingmentice.com

Mentice builds VR and physical simulation platforms for image-guided interventional therapies, serving practicing interventional physicians, healthcare systems, and MedTech companies across neurovascular, cardiovascular, and peripheral vascular procedures. Its portfolio includes VIST simulators, Ankyras clinical decision support, and physiological flow systems.

What Mentice does

Mentice AB is a Swedish medical simulation company founded in 1999 and headquartered in Gothenburg, building virtual reality and physical simulation platforms for image-guided interventional therapies (IGIT). The company's core technology is the VIST (Vascular Intervention Simulation Trainer) hardware line (VIST G5 and G7), which uses haptic feedback, procedural replication, and integration with live angiosuites and interventional robotics to train and credential interventional neuroradiologists, cardiologists, and radiologists across neurovascular, cardiovascular, and peripheral vascular procedures. The portfolio also includes Physiological Flow Systems that reproduce realistic vascular disease states, the Vascular Twin (case-it) patient-specific anatomical replicator, the LAACS and Replicator PRO devices, and procedural learning modules covering more than 25 clinical areas. Following the 2022 acquisition of Ankyras from Galgo Medical S.L., Mentice operates a regulated clinical decision support application for intracranial flow diverter sizing, with manufacturing and R&D housed in Mentice Spain S.L. in Barcelona.

The company earns revenue through one-time hardware sales of simulator platforms and consumables (silicone and 3D-printed vessels, blood solutions, clot replication materials), recurring software revenue from AnkyRAS, Mentice Live, and learning modules, and professional services covering installation, training, and extended warranty. Pricing is quote-based under multi-year enterprise contracts, sold via direct field sales to healthcare systems and MedTech OEMs and supported by regional distributors in international markets. Named partners include Siemens Healthineers, Stryker, Cordis, and the Jacobs Institute. Mentice reports 115 employees, presence in 8 countries, and turnover of SEK 279 million in 2025, with strategic focus split between practicing physicians and trainees, healthcare executives standardizing training programs, and MedTech industry partners using Mentice solutions for device development, sales demonstration, and professional education.

Mentice firmographics

Firmographics
Name
Mentice
Legal name
Mentice AB
Website
https://mentice.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
101–250 employees
Short description
Mentice builds VR and physical simulation platforms for image-guided interventional therapies, serving practicing interventional physicians, healthcare systems, and MedTech companies across neurovascular, cardiovascular, and peripheral vascular procedures. Its portfolio includes VIST simulators, Ankyras clinical decision support, and physiological flow systems.
Ownership category
akta.pro rank

Mentice industry classification

Industry
Product category
Medical Simulation and Training
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYEDAFAJAC
Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction)
Education/Education Technology (EdTech) & Digital Learning/AR/VR/XR, Simulations & Immersive Learning
SECONDARYEDAFAJAJ
Digital Twins & Scenario-Based Systems Training (Equipment/Process Simulators)
Education/Education Technology (EdTech) & Digital Learning/AR/VR/XR, Simulations & Immersive Learning
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Medical simulation platforms
  • Interventional radiology training
  • Vascular intervention simulation
  • Clinical decision support
  • Endovascular procedure training

Where Mentice is headquartered

Location

Headquarters

HQ city
Gothenburg
HQ country
Sweden
HQ region
Europe

Offices2 records

Markets served

Mentice business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Virtual Simulation Platforms and Hardware: Sale of VR simulator platforms (VIST G5, VIST G7) and related hardware including flow systems, silicone vessels, and accessories. These are physical products sold as one-time purchases with associated consumables and service contracts.
  2. Software Licenses and Subscriptions: Software solutions including procedural learning modules, ANKYRAS clinical decision support application, and cloud-based Mentice Live platform. May include subscription-based access to software updates and cloud services.
  3. Professional Services: Installation, training, and extended warranty services, as well as device and procedural development services for MedTech industry partners
  4. Consumables: Flow system accessories including realistic blood solutions, clot replication materials, and cleaning solutions for physical simulators

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise healthcare systems pricing

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Mentice product offering

Product offering

Core offering

Mentice develops and sells virtual reality and physical simulation platforms for image-guided interventional therapies, including endovascular, neurovascular, cardiovascular, and peripheral vascular procedures. Its core product family is the VIST (Vascular Intervention Simulation Trainer) platform (G5 and G7), complemented by the Ankyras clinical decision support application for flow diverter sizing, Mentice Live cloud-based proctoring, Vascular Twin patient-specific anatomical replication, Physiological Flow Systems, and related consumables and learning modules used by hospitals, physicians, and MedTech companies.

Product overview

Mentice is a specialist in proficiency-based simulation solutions for image-guided interventional therapies (IGIT), offering both virtual reality and physical simulation platforms. The product portfolio centers on VIST (Vascular Intervention Simulation Trainer) hardware platforms (VIST G5 and G7), complemented by Ankyras (acquired 2022) for clinical decision support in flow diverter sizing, Vascular Twin for patient-specific anatomical replication, and cloud/mobile applications including Mentice Live and the Right Heart Cath App. The ecosystem includes Procedural Learning Modules (25+ clinical areas), Physiological Flow Systems for physical simulation, and supporting consumables. Solutions serve healthcare professionals (practicing physicians, residents, fellows) and MedTech industry (R&D, sales, professional education) across neurovascular, cardiovascular, and peripheral vascular specialties. Mentice operates from Gothenburg, Sweden with 115 employees and presence in 8 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Ankyras: Clinical decision support application for flow diverter sizing in intracranial aneurysm treatment
  • VIST (Vascular Intervention Simulation Trainer)
  • Mentice Live
  • Vascular Twin (case-it)
  • Physiological Flow Systems
  • Replicator PRO
  • LAACS

Products and services

  • VIST G7 Simulator Latest generation virtual reality vascular intervention simulation platform with advanced haptic feedback for realistic catheter and device manipulation training in neurovascular, cardiovascular, and peripheral vascular procedures; used by hospitals, training programs, and MedTech companies.
  • VIST G5 Simulator Fifth generation haptic device-based endovascular simulator enabling realistic catheter and device manipulation training for interventional procedures; targeted at healthcare systems and training programs.
  • Ankyras Clinical decision support software application that imports patient anatomy and determines the optimal flow diverter size for intracranial aneurysm treatment; used by interventional neuroradiologists and neurosurgeons, with CE MDR, UKCA, FDA 510(k), and ANVISA clearances.
  • Mentice Live Cloud-based platform combining remote proctoring and online learning capabilities with medical simulation, enabling distributed training, curriculum delivery, and remote expert guidance for interventional teams.
  • Vascular Twin (case-it) Real anatomical replication solution that imports patient CT, MRI, or 3DRA imaging to build a library of patient-specific cases for pre- and post-intervention practice.
  • Right Heart Cath App Mobile application providing interactive, real-time exploration of the right heart catheterization (RHC) procedure for portable training access by interventional cardiologists and trainees.
  • Physiological Flow Systems Physical simulation systems that replicate valvular, peripheral, aortic vascular, and neurovascular disease states with realistic blood flow for device and procedural training and adoption; used by hospitals and medical device manufacturers.
  • Silicone & 3D Printed Vessels Patient-specific anatomical vessels in silicone and 3D printed formats, ordered to patient anatomy or chosen from a catalogue of anatomies for physical simulation training.
  • Flow System Accessories Consumables for physical flow simulators, including realistic SIMulant blood solutions, clot replication and extraction materials, and cleaning solutions.
  • Professional Services Professional services covering installation, training, and extended warranty for Mentice simulation platforms, plus device and procedural development services for MedTech industry partners.

Companies that use Mentice

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Mentice technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature6 records

Mentice partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor and core.

  • VinnovaminorOthers · 9 November 2022Swedish government innovation agency providing 3 million SEK grant to enhance realism in virtual reality software and synthetic image generation for medical AI training as part of the TASTI initiative within the European Eureka Xecs cluster.
  • Galgo Medical S.L.coreTechnology or Integration · 9 June 2022Acquired all assets related to the Ankyras software solution for approximately EUR 2.775 million in cash. Ankyras provides flow diverter sizing for intracranial aneurysm treatment planning.
  • Siemens HealthineerscoreGTM or Marketing PartnerCo-marketing partnership to advance neurovascular treatment planning. The partnership combines Mentice's simulation expertise with Siemens Healthineers' imaging technology to provide integrated solutions for neurovascular procedures.
  • Jacobs InstitutecoreStrategic or Co-development PartnerHealthcare innovation partner focused on advancing medical device development and training. Mentice provides simulation technology for the institute's education and research programs.
  • StrykercoreGTM or Marketing PartnerStrategic MedTech partner using Mentice simulation solutions for device adoption, physician training, and demonstrating clinical credibility of their medical devices.
  • CordiscoreGTM or Marketing PartnerMedTech industry partner leveraging Mentice solutions for procedural training and professional education related to Cordis medical devices.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Mentice competitors and assessment

Company assessment

Direct peers

  • Surgical Science Sweden AB: Swedish-headquartered medical simulation company offering virtual reality training platforms for interventional and surgical procedures. The closest direct competitor to Mentice, with overlapping endovascular, cardiovascular, and minimally invasive surgery simulation product lines and a shared Gothenburg regional base.
  • VirtaMed: Swiss developer of high-fidelity virtual reality simulators for endovascular, laparoscopic, and ultrasound-guided procedures. Directly competes with Mentice in interventional cardiology, interventional radiology, and vascular access training served to the same MedTech and hospital buyers.
  • Simbionix (3D Systems): 3D Systems' healthcare division produces the Simbionix line of VR-based procedural simulators for endovascular, bronchoscopy, GI, and general surgery. It is a direct competitor in virtual interventional simulation with comparable procedural content and an established global installed base.
  • Medical-X: Netherlands-based developer of virtual reality and simulation-based training systems for minimally invasive surgery, endovascular, and interventional procedures. A direct competitor at the specialty-procedural simulator level with comparable product pricing tiers.

Broad incumbents

  • CAE Healthcare: Healthcare division of CAE Inc. providing a broad portfolio of simulation-based training solutions spanning patient, ultrasound, interventional, and surgical modalities. While larger and broader than Mentice, it competes in healthcare simulation procurement at large hospital systems and MedTech training programs.
  • Laerdal Medical: Norwegian-based global leader in medical simulation, including patient, emergency, and resuscitation training. While focused on patient simulators rather than interventional procedures, it competes at the healthcare-system training budget level and brings significant scale and distribution.
  • Gaumard Scientific: U.S.-based manufacturer of patient simulators and simulation-based training solutions used across nursing, medical, and emergency response education. Operates broadly across healthcare simulation procurement where Mentice also targets healthcare executive buyers.

Emerging players

  • Osso VR: VR-based surgical and procedural training platform for orthopedic, spine, and interventional procedures. Offers a software-first, more scalable model that competes with Mentice on content breadth and remote training capability (overlapping with Mentice Live).
  • FundamentalVR: Haptic-enabled VR surgical training platform deployed via SaaS to MedTech and hospital customers. Competes with Mentice in MedTech professional education and surgical skills training, with a more software-centric approach.
  • Inovus Medical: U.K.-based developer of synthetic and digital training solutions for surgical and interventional procedures, including laparoscopic and endovascular simulators. An emerging competitor addressing a portion of Mentice's procedural training market with cost-positioned offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Mentice social profiles

Digital presence

Mentice compliance and trust

Trust signal

Compliance6 records

Mentice financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mentice leadership team

Management profile

Number of profiles

Profiles5 records

Mentice subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Mentice funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mentice M&A and investment

M&A and investment

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mentice

What does Mentice do?

Mentice develops and sells virtual reality and physical simulation platforms for image-guided interventional therapies, including endovascular, neurovascular, cardiovascular, and peripheral vascular procedures. Its core product family is the VIST (Vascular Intervention Simulation Trainer) platform (G5 and G7), complemented by the Ankyras clinical decision support application for flow diverter sizing, Mentice Live cloud-based proctoring, Vascular Twin patient-specific anatomical replication, Physiological Flow Systems, and related consumables and learning modules used by hospitals, physicians, and MedTech companies.

Is Mentice a public or private company?

Mentice is a private company. It is classified as public and is currently operating.

When was Mentice founded?

Mentice was founded in 1999. It employs 101 to 250 people.

Where is Mentice based?

Mentice is headquartered in Gothenburg, Sweden, in the Europe region.

How does Mentice make money?

Four revenue lines are on record. Virtual Simulation Platforms and Hardware is the primary driver. The others are software Licenses and Subscriptions, professional Services and consumables.

Who are Mentice's main competitors?

Direct peers on record are Surgical Science Sweden AB, VirtaMed, Simbionix (3D Systems) and Medical-X. Broad incumbents are CAE Healthcare, Laerdal Medical and Gaumard Scientific. Emerging players are Osso VR, FundamentalVR and Inovus Medical.

Does Mentice have an API?

No public API is recorded for Mentice.

What industry is Mentice in?

Mentice's product category is Medical Simulation and Training. Its primary akta.pro industry code is EDAFAJAC, Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction), with a secondary code of EDAFAJAJ, Digital Twins & Scenario-Based Systems Training (Equipment/Process Simulators). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Simply Wall StHere's What Analysts Are Forecasting For Mentice AB (publ) (STO:MNTC) After Its Third-Quarter ResultsMentice AB reported Q3 revenues of kr73m, missing estimates by 4.9%, and a statutory loss of kr0.51 per share. Analysts now forecast 2027 revenues of kr353.7m and EPS of kr0.39, down from earlier estimates, while the consensus price target remains at kr22.75.Dagens industriHögre orderingång för Mentice – resultatet på minusMentice reported a Q3 2026 EBITDA of -6.2 million SEK, including -8.5 million SEK in one-off adjustments. The company, a surgical simulation technology provider, posted the loss for the third quarter of 2026.The future of tradingMentice publishes its interim report for the period July–September 2026Mentice reported Q3 2026 net sales of 72.6 MSEK, up 0.8% organically, with order intake of 73.1 MSEK, up 27.8% organically. Net income fell to -14.3 MSEK, and EBITDA was -6.2 MSEK, including -8.5 MSEK of one-off adjustments. The company will present the interim report on November 10, 2026.TradingViewMentice to Present Q3 2026 Interim Report via WebcastMentice AB will present its Q3 2026 interim report via webcast on November 10, 2026, at 10:00 CET. CEO Frans Venker and CFO Rick van Veen will cover financial performance, key developments, and strategic priorities, followed by a Q&A session.The future of tradingDNB Carnegie Access: Analyspodden - Avsnitt 384 - Mentice – från transformation till tillväxt och marginallyftMentice, a Swedish medtech training company, has reported four consecutive quarters of net revenue growth and improving EBITDA. The company's solutions simulate minimally invasive procedures for hospitals and surgeons. The episode discusses its growth potential and financial targets.YahooMentice AB (FRA:MN2) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...Mentice AB reported Q2 2026 earnings with 28% year-over-year revenue growth reaching SEK80 million, driven by 41% organic growth in order intake. The company swung to EBITDA profitability of SEK6.3 million from a loss of SEK8 million a year prior, while cash position strengthened to SEK61 million from SEK26 million. Management cited a 3-to-4 month revenue recognition lag for project orders and noted margin pressure from foreign exchange impacts and manufacturing outsourcing.Dagens industriOrderingången ökade för MenticeMentice reported an EBITDA of 6.3 million Swedish kronor for Q2 2026, despite a previous loss of 8.1 million kronor, indicating improved financial performance. The company is involved in the medical simulation technology sector, serving surgical training needs.AInvestMentice secures $2.4M in several orders from one top 20 global medtech company in interventional cardiology, focused on structural heart diseaseMentice has received several orders totaling $2.4 million from a top 20 global medtech company specializing in interventional cardiology with a focus on structural heart disease. The orders are for Mentice's simulation-based training solutions designed to support clinical education and procedural skill development in complex cardiac interventions. The transaction is expected to contribute to Mentice's revenue growth in the current fiscal year and aligns with the company's strategy to expand its presence in high-growth segments of the healthcare technology market.PharmiWeb.comMentice Appoints Rick van Veen as Chief Financial Officer and Announces Changes to the Executive Management GroupMentice AB announced the appointment of Rick van Veen as Chief Financial Officer, effective July 1, 2026, bringing extensive experience from a global MedTech company. Current CFO Ulrika Drotz will depart on August 1, 2026 after a transition period, while current COO Jonatan Sjöström will leave on April 30, 2026. The company is restructuring its Executive Management Group to increase speed and impact, though it confirms business operations remain unchanged and emphasizes continued focus on sustainable, profitable growth.